| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H24N2O2 |
| Molecular Weight | 384.4703 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OC1=C2N=CC=CC2=CC=C1)C3=CN(CC4CCCCC4)C5=CC=CC=C35
InChI
InChIKey=RHYGTJXOHOGQGI-UHFFFAOYSA-N
InChI=1S/C25H24N2O2/c28-25(29-23-14-6-10-19-11-7-15-26-24(19)23)21-17-27(16-18-8-2-1-3-9-18)22-13-5-4-12-20(21)22/h4-7,10-15,17-18H,1-3,8-9,16H2
| Molecular Formula | C25H24N2O2 |
| Molecular Weight | 384.4703 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.338 nM [Ki] | |||
| 0.217 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|